Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Investor presentation - Bioxyne Limited
Health
Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| 0.00% | 26 Nov 2020 |
| 0.00% | 28 Oct 2020 |
| 0.00% | 27 Oct 2020 |
| 0.00% | 30 Sep 2020 |
| 0.00% | 30 Sep 2020 |
| 0.00% | 30 Aug 2020 |
| -22.22% | 20 Aug 2020 |
| -21.43% | 30 Jul 2020 |
| 0.00% | 01 May 2020 |
| 0.00% | 30 Apr 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,048
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:BXN is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia